Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
Abivax After the Hype - A Fundamental-First Long Trade (With Risk Controls)
Obefazimod momentum is real, but execution, dilution and safety will decide whether this becomes a durable biotech winner
Abivax (ABVX) is a classic catalyst-driven biotech: a Phase 3 asset (obefazimod) has produced market-moving data and headlines, and the stock has alre...
Centrus Energy (LEU) - Tactical Buy After Meta Sparks a Nuclear Rerating
Use a disciplined entry and tight stop to play a policy- and contract-driven rally in uranium enrichment
Centrus Energy jumped into the spotlight after high-profile commercial interest in advanced nuclear fuel. The stock is tradable here on a tactical, sw...
Toll Brothers: Upgrade to Long - Recovery Looks Real and Tradeable
Strong margins, healthy cash flow and a conservative balance sheet give Toll Brothers upside as housing sentiment inflects
Toll Brothers (TOL) is showing improving profitability, consistent operating cash flow and an intact balance sheet. Recent execution on speculative "q...
Thryv Holdings: Deep-Value Buy—Ignore Near-Term Noise, Back the Turnaround
SaaS transition and debt paydown create an asymmetric risk-reward at ~$5.55; buy with tight risk control.
Thryv (THRY) is trading near multi-year lows after volatile quarters and one-off write-downs. Recent results show revenue stabilization, positive oper...
StoneX (SNEX): A Volatility-Resilient Compounder — Buy the Pullbacks, Hold Through Integrations
Scale and cash flow from diversified trading, payments and acquisitions make SNEX a defensive growth trade into 2026
StoneX is increasingly a diversified financial-services platform: high top-line flow, recurring trading revenue, strong operating cash flow and a stri...
Valens Semiconductor - The Rerating Is Just Starting: A Volatility-Fueled Long Idea
Buy the breakout, size for volatility — entry 2.20-2.60, stop 1.65, targets 3.50 / 5.00
Valens (VLN) is showing the hallmarks of an early rerating: a large buyback authorization, outsized volume spikes and a sustained move off 12-month lo...
Ferrari Reset: De-Risked Setup and a Tradeable Re-Rate After the Pullback
Shareholder clarity, buybacks and a healthy cash return profile make RACE a tactical long with clear entry/ stop and targets
Ferrari's governance noise has been dialed down, buybacks restarted and dividend policy progressive — yet the stock is trading roughly 27% off 2025 ...
Capital Southwest (CSWC) - Income Still Works, But Don’t Expect Last-Cycle Magic
High yield and steady distributions make CSWC a tactical income buy; position size should reflect credit and interest-rate uncertainty.
Capital Southwest is offering an attractive double-digit yield today with a track record of monthly regular dividends and supplemental payouts. Balanc...
Phillips 66 (PSX) - Upgrade to Long: Positioned to Win from a Venezuela Reopening
Scale, midstream reach and a growing capital plan make PSX my preferred refined-products play if heavy crude flows return.
Phillips 66 is a large independent refiner and midstream operator with the scale and balance-sheet flexibility to benefit disproportionately if Venezu...
Nurix (NRIX) - Clinical Momentum Creates Asymmetric Long Opportunity
BTK degrader data + DAYBreak pivotal give upside; balance sheet and recent financing limit tail risk — trade with tight sizing and a clear stop.
Nurix has converted Phase 1 signals into a program-level catalyst run: positive BTK degrader (bexobrutideg / NX-5948) and CBL-B (NX-1607) readouts, a ...
MarketWise (MKTW) — Deep Value, High Yield, and a Trade Set-Up Around Parent-Class Scarcity
Small public float, constructive revenue trends, big dividends and corporate activity make a tactical long with defined risk controls.
MarketWise's Class A shares trade against a consolidated business that is generating meaningful operating cash flow. After accounting for the post-202...
Coinbase: Buy the Regulation-Backed Exchange on a Pullback - Long-Term Thesis Intact
Q3 2025 showed profitable growth and a clean balance sheet; trade plan gives asymmetric upside into Q4 while respecting crypto cyclicality.
Coinbase delivered solid profitability in Q3 2025 (09/30/2025) with $1.87B revenue and $432.6M net income, and it still sits on a balance sheet with $...